To test this hypothesis, we used an in vitro model to generate suppressive tumor-educated myeloid-derived CD33+ cells, which are subsequently referred to as MDSC-like cells, by adapting the protocol from Lechner et al. [26] (Fig. 5A). Here, CD33 is linked to neoplasm.